X. Lam

发表

Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.

J L Cleland, J. Cleland, E. Duenas, 2001, Journal of pharmaceutical sciences.

Aggregation of recombinant human interferon gamma: kinetics and structural transitions.

M. Manning, J. Carpenter, T. Randolph, 1998, Journal of pharmaceutical sciences.

In vitro stability and compatibility of tenecteplase in central venous access devices

Y. Lentz, X. Lam, Michael Joyce, 2011, Hemodialysis international. International Symposium on Home Hemodialysis.

Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor.

M. Manning, J. Carpenter, T. Randolph, 2000, Journal of pharmaceutical sciences.

Replacing succinate with glycolate buffer improves the stability of lyophilized interferon-γ

Chung C. Hsu, H. Costantino, T. Nguyen, 1996 .

Kinetic Modeling of Methionine Oxidation in Monoclonal Antibodies from Hydrogen Peroxide Spiking Studies

Y. J. Wang, U. Grauschopf, X. Lam, 2015, PDA Journal of Pharmaceutical Science and Technology.

Site-Specific Tryptophan Oxidation Induced by Autocatalytic Reaction of Polysorbate 20 in Protein Formulation

Chung C. Hsu, Victor Ling, X. Lam, 2011, Pharmaceutical Research.

A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.

J L Cleland, Chung C. Hsu, J. Carpenter, 2001, Journal of pharmaceutical sciences.

The Effect of Benzyl Alcohol on Recombinant Human Interferon-γ

T. Patapoff, T. Nguyen, X. Lam, 1997, Pharmaceutical Research.

Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.

X. Lam, C. A. Ward, C. Du Mee, 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2.

J L Cleland, J. Cleland, X. Lam, 1997, Journal of pharmaceutical sciences.

Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes.

J L Cleland, A. Daugherty, J. Cleland, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of Heavy-Chain C-Terminal Deletion on Product Quality and Pharmacokinetics of Monoclonal Antibodies.

Y. J. Wang, Kai Zheng, P. Wong, 2016, Journal of pharmaceutical sciences.